In 2019, the Center for Drug Evaluation (CDE) of China reviewed and approved a total of 8730 drug registration applications. As a follow-up on part 2 of Drug Evaluation Report 2019, part 3 further gives an overview of drug approvals for all application types (incl. IND registrations), drug priority review & accelerated approvals, and drug…
On 2nd July, 2019, China CDE-NMPA published the 2018 working Report, summarizing the drug review and approval statistic data in the past year. See below for the details. 8- Statistic of Traditional Chinese Medicine – Overall 9- Statistic of Traditional Chinese Medicine -IND 10- Statistic of Traditional Chinese Medicine -NDA
On 2nd July, 2019, China CDE-NMPA published the 2018 working Report, summarizing the drug review and approval statistic data in the past year. See below for the details. 5- Statistic of Biological Products – Overall 6- Statistic of Biological Products -IND 7- Statistic of Biological Products -NDA
On 2nd July, 2019, China CDE-NMPA published the 2018 working Report, summarizing the drug review and approval statistic data in the past year. See below for the details. 1- Overall Statistic It can be seen from Figure 1, 2, 3 and 4, the backlog of drug applications in CDE has been greatly alleviated: the application…
